A functional screen for regulators of CKDN2A reveals MEOX2 as a transcriptional activator of INK4a

Jeffrey T Irelan1, Ana Gutierrez Del Arroyo, Abel Gutierrez

  • 1Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA. jirelan@gmail.com

Plos One
|April 3, 2009
PubMed

Insights

Researchers identified novel activators of the CDKN2A tumor suppressor locus, including the homeodomain protein MEOX2. MEOX2 directly regulates INK4a transcription and induces cellular senescence, revealing a new mechanism in tumor suppression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The CDKN2A locus produces INK4a and ARF tumor suppressors.
  • These proteins induce cellular senescence in response to oncogenic stress.

Purpose of the Study:

  • Identify novel transcriptional activators of the CDKN2A locus.
  • Investigate the role of MEOX2 in regulating INK4a and senescence.

Main Methods:

  • Genome-scale cDNA overexpression screen using an INK4a reporter.
  • Validation of candidate genes, including homeodomain proteins.
  • Chromatin immunoprecipitation to assess MEOX2 binding to the INK4a promoter.

Main Results:

  • Identified 285 potential transcriptional activators of CDKN2A.
  • Validated 14 genes, including homeodomain proteins.
  • MEOX2 (GAX) expression increased during senescence and induced premature senescence.
  • MEOX2 directly binds the INK4a promoter and its senescence-inducing role is INK4a-dependent.

Conclusions:

  • MEOX2 is a novel, direct transcriptional activator of the INK4a locus.
  • MEOX2 plays a significant role in regulating INK4a transcription and inducing cellular senescence.
  • These findings offer new insights into tumor suppressor regulation and senescence pathways.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...